Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
SGMO | SANGAMO THERAPEUTICS, INC | Fontenot Jason D. | SVP, Chief Scientific Officer | Nov 25, 2023 | Option Exercise | $0.38 | 1,030 | 394 | 136,270 | Nov 28, 2023, 04:18 PM | |
SGMO | SANGAMO THERAPEUTICS, INC | Fontenot Jason D. | SVP, Chief Scientific Officer | Aug 25, 2023 | Option Exercise | $0.77 | 1,029 | 792 | 137,300 | Aug 29, 2023, 04:15 PM | |
SGMO | SANGAMO THERAPEUTICS, INC | Fontenot Jason D. | SVP, Chief Scientific Officer | May 25, 2023 | Option Exercise | $1.33 | 1,029 | 1,369 | 138,329 | May 30, 2023, 04:42 PM | |
SGMO | SANGAMO THERAPEUTICS, INC | Fontenot Jason D. | SVP, Chief Scientific Officer | Feb 25, 2023 | Option Exercise | $2.66 | 6,559 | 17,447 | 139,358 | Mar 06, 2023, 05:07 PM | |
SGMO | SANGAMO THERAPEUTICS, INC | Fontenot Jason D. | SVP, Chief Scientific Officer | Apr 25, 2022 | Option Exercise | $4.83 | 826 | 3,990 | 103,167 | Apr 27, 2022, 05:09 PM | |
SGMO | SANGAMO THERAPEUTICS, INC | Fontenot Jason D. | SVP, Chief Scientific Officer | Feb 25, 2022 | Option Exercise | $5.90 | 6,248 | 36,863 | 58,893 | Mar 01, 2022, 05:18 PM | |
SGMO | SANGAMO THERAPEUTICS, INC | Fontenot Jason D. | SVP, Chief Scientific Officer | Apr 25, 2021 | Option Exercise | $11.71 | 811 | 9,497 | 62,496 | Apr 27, 2021, 08:49 PM |